Buparlisib companion diagnostic - Novartis
Alternative Names: BKM 120 companion diagnostic - NovartisLatest Information Update: 04 Nov 2017
At a glance
- Originator Novartis
- Class Diagnostic agents
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Breast cancer; Non-small cell lung cancer; Prostate cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Breast-cancer(Diagnosis) in European Union
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Breast-cancer(Diagnosis) in USA
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Non-small-cell-lung-cancer(Diagnosis) in European Union